The Latest Breaking News from Pfizer

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities

Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

The Second Circuit divides over whether an association must identify an injured member by name for the purposes of Article III. (Updated)

The government isn’t doing much to prevent shortages of the only drug that treats syphilis during pregnancy

There are other reasons to consider buying a dividend stock besides the high yield. Here's a closer look at two stocks that offer yields over 5% right now.

Bayer snagged commercial rights to BridgeBio's lead asset, acoramidis, in Europe for $310 million. But BridgeBio stock tumbled Monday.

While the S&P 500 Index's dividend yield is just about half of its long-term averages, Ford and Pfizer are two dividend-paying stocks that offer healthy yields. Plus, their cheap valuations mean that there is a reasonable probability of upside over the next couple of years.